The drug price controls in the Inflation Reduction Act (IRA) will have a far more serious impact on new drug development than previously expected, …
IRA means 40% reduction in new drugs over 10 years, report finds Read More »
Pfizer’s ABRYSVO vaccine for respiratory syncytial virus (RSV) received U.S. Food and Drug Administration (FDA) approval for use in adults over age 60 on …
FDA approves Pfizer’s RSV vaccine for adults over age 60 Read More »
Two bills to create a healthy investment environment for biotech startups passed the House late May 30 with overwhelming bipartisan support. The legislation was …
BIO-backed bills that would support startups passed by House Read More »
The EU Pharmaceutical Package is a series of legislative proposals that aims to, among other things, improve access, affordability, and availability of medicinal products …
Breaking down the EU Pharmaceutical Package: What U.S. companies should know Read More »
Along with climate change comes longer, warmer months, which means an extended tick season. With more time spent outdoors, there’s an inevitable increase in …
Ticking time bomb: reviving Lyme disease awareness Read More »
On May 21, the 90th Paris assembly for World Organisation for Animal Health (WOAH) announced concern over the dramatic rise in cases of avian …
Avian flu vaccine discussed by WOAH general session: the potential of a new pandemic Read More »
Key legislation providing greater transparency and oversight into the 340B federal drug program moved forward in the U.S. House on May 25. The House …
On May 23, the House Committee on Oversight and Accountability sought to answer this question: are PBMs (pharmacy benefit managers) working in the interest …
Are PBMs working in the interest of health care – or themselves? Read More »
As the Biotechnology Innovation Organization (BIO) prepares for the June 5-8 International Convention in Boston, the I am BIO Podcast explores how that city …
I am BIO podcast explores how Boston became a ‘biotech hub’ Read More »
The Biotechnology Innovation Organization (BIO), along with its members, sent a letter to Congressional leadership earlier this month urging for legislative action to be …
Why Congress must repeal the R&D amortization provision Read More »
